Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024
Celebrates 30 Years of Innovation Through Collaboration and the Development of Technologies That Have Helped Set the Standard of Care for the Industry
MADISON, Wis., April 25, 2024 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife® and Radixact® platforms provide medical care teams with the technology necessary for expanding the curative power of radiation therapy and delivering on the focus of this year’s congress, bridging the care gap. The European Society for Radiotherapy and Oncology’s (ESTRO) annual meeting will take place May 3 to May 7, 2024, in Glasgow, Scotland.